These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7719068)

  • 1. [Isotretinoin administration in treatment of acne vulgaris. A prospective study of the kind and extent of ocular complications].
    Egger SF; Huber-Spitzy V; Böhler K; Scholda C
    Ophthalmologe; 1995 Feb; 92(1):17-20. PubMed ID: 7719068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tearfilm and conjunctival flora.
    Egger SF; Huber-Spitzy V; Böhler K; Raff M; Scholda C; Barisani T; Vecsei VP
    Acta Ophthalmol Scand; 1995 Aug; 73(4):355-7. PubMed ID: 8646585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
    Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
    Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacrimal function and ocular complications in patients treated with systemic isotretinoin.
    Bozkurt B; Irkeç MT; Atakan N; Orhan M; Geyik PO
    Eur J Ophthalmol; 2002; 12(3):173-6. PubMed ID: 12113560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dose-related ocular side effects during systemic isotretinoin administration.
    Cumurcu T; Sezer E; Kilic R; Bulut Y
    Eur J Ophthalmol; 2009; 19(2):196-200. PubMed ID: 19253234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment.
    Caglar C; Senel E; Sabancilar E; Durmus M
    Int Ophthalmol; 2017 Feb; 37(1):197-202. PubMed ID: 27193123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The results and side effects of systemic isotretinoin treatment in 100 patients with acne vulgaris.
    Kaymak Y; Ilter N
    Dermatol Nurs; 2006 Dec; 18(6):576-80. PubMed ID: 17286159
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenesis of blepharoconjunctivitis complicating 13-cis-retinoic acid (isotretinoin) therapy in a laboratory model.
    Lambert RW; Smith RE
    Invest Ophthalmol Vis Sci; 1988 Oct; 29(10):1559-64. PubMed ID: 3170128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis.
    Elubous KA; Toubasi AA; Elubous A; Alryalat SA; Abous H
    Cutan Ocul Toxicol; 2022 Jun; 41(2):113-122. PubMed ID: 35296199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meibomian gland morphology and tear osmolarity: changes with Accutane therapy.
    Mathers WD; Shields WJ; Sachdev MS; Petroll WM; Jester JV
    Cornea; 1991 Jul; 10(4):286-90. PubMed ID: 1832371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the systemic isotretinoin treatment on ocular surface and meibomian glands: a prospective longitudinal study.
    Acar Eser N; Kocabeyoğlu S; Atakan N; Irkec M
    Cutan Ocul Toxicol; 2022 Jun; 41(2):155-161. PubMed ID: 35609140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmological effects of 13-cis-retinoic acid therapy for acne vulgaris.
    Milson J; Jones DH; King K; Cunliffe WJ
    Br J Dermatol; 1982 Oct; 107(4):491. PubMed ID: 6215054
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy.
    Yılmaz U; Küçük E; Koç Ç; Gökler E
    Curr Eye Res; 2017 Jun; 42(6):827-831. PubMed ID: 28139163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of systemic isotretinoin treatment on the tear film, meibomian glands, and corneal endothelium.
    Demir K; Uzun F
    Cutan Ocul Toxicol; 2024 Sep; 43(3):176-181. PubMed ID: 38873903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical acne treatment on the ocular surface in patients with acne vulgaris.
    Aslan Bayhan S; Bayhan HA; Çölgeçen E; Gürdal C
    Cont Lens Anterior Eye; 2016 Dec; 39(6):431-434. PubMed ID: 27422575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial.
    Aragona P; Cannavò SP; Borgia F; Guarneri F
    Br J Dermatol; 2005 Mar; 152(3):576-8. PubMed ID: 15787837
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular surface characteristics in acne vulgaris.
    Muhafiz E; Öztürk M; Erten R
    Clin Exp Optom; 2022 Jan; 105(1):65-69. PubMed ID: 33719904
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of oral isotretinoin on visual contrast sensitivity and amount of lacrimation in patients with acne vulgaris.
    Polat M; Kükner Ş
    Cutan Ocul Toxicol; 2017 Mar; 36(1):35-38. PubMed ID: 26911891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin and one patient's teary eyes: "please listen or I'll cry".
    Elpern DJ
    Int J Dermatol; 2013 Jun; 52(6):757-8. PubMed ID: 23679883
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of recovery time of tear film function and ocular surface after discontinuing oral isotretinoin treatment for acne vulgaris : Correlation between oral isotretinoin and tear film function.
    Lekskul M; Thaiwat S; Lekvijittada J
    Int Ophthalmol; 2023 Dec; 43(12):4683-4688. PubMed ID: 37688653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.